Mahmoud Hammad

Dr. Mahmoud Hammad

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2021 in eLife
Verified
Journal Article
Open access
MBMohamed A Badawy
Mohamed A Badawy
BYBasma A Yasseen
Basma A Yasseen
RERiem M El-Messiery
Riem M El-Messiery
EAEngy A Abdel-Rahman
Engy A Abdel-Rahman
Aya ElkhodiryAya Elkhodiry
Aya Elkhodiry
SASameh Ali
Sameh Ali
Human serum albumin (HSA) is the frontline antioxidant protein in blood with established anti-inflammatory and anticoagulation functions. Here, we report that COVID-19-induced oxidative stress inflicts structural damages to HSA and is linked with mortality outcome in critically ill patients. We recruited 39 patients who were followed up for a median of 12.5 days (1–35 days), among them 23 had died. Analyzing blood samples from patients and healthy individuals (n=11), we provide evidence that neutrophils are major sources of oxidative stress in blood and that hydrogen peroxide is highly accumulated in plasmas of non-survivors. We then analyzed electron paramagnetic resonance spectra of spin-labeled fatty acids (SLFAs) bound with HSA in whole blood of control, survivor, and non-survivor subjects (n=10–11). Non-survivors’ HSA showed dramatically reduced protein packing order parameter, faster SLFA correlational rotational time, and smaller S/W ratio (strong-binding/weak-binding sites within HSA), all reflecting remarkably fluid protein microenvironments. Following loading/unloading of 16-DSA, we show that the transport function of HSA may be impaired in severe patients. Stratified at the means, Kaplan–Meier survival analysis indicated that lower values of S/W ratio and accumulated H2O2 in plasma significantly predicted in-hospital mortality (S/W≤0.15, 81.8% (18/22) vs. S/W>0.15, 18.2% (4/22), p=0.023; plasma [H2O2]>8.6 μM, 65.2% (15/23) vs. 34.8% (8/23), p=0.043). When we combined these two parameters as the ratio ((S/W)/[H2O2]) to derive a risk score, the resultant risk score lower than the mean (<0.019) predicted mortality with high fidelity (95.5% (21/22) vs. 4.5% (1/22), log-rank χ2=12.1, p=4.9×10−4). The derived parameters may provide a surrogate marker to assess new candidates for COVID-19 treatments targeting HSA replacements and/or oxidative stress.

1 November 2021 in Clinical Lymphoma Myeloma and Leukemia
Verified
Journal Article
Closed access
MHMahmoud Hammad
Mahmoud Hammad
LSLobna Shalaby
Lobna Shalaby
ISIman Sidhom
Iman Sidhom
NSNancy Sherief
Nancy Sherief
IAIbrahim Abdo
Ibrahim Abdo
AEAlaa Elhaddad
Alaa Elhaddad

5 March 2025 in Leukemia
Verified
Journal Article
Closed access
PDF file
FMFrédéric Millot
Frédéric Millot
MAMirella Ampatzidou
Mirella Ampatzidou
NMNirmalya Roy Moulik
Nirmalya Roy Moulik
STSanjay Tewari
Sanjay Tewari
AEAlaa Elhaddad
Alaa Elhaddad
MSMeinolf Suttorp
Meinolf Suttorp

17 January 2022 in Acta Oncologica
Verified
Journal Article
Closed access
MEMariam Mohamed Elsherif
Mariam Mohamed Elsherif
MHMahmoud Hammad
Mahmoud Hammad
HHHanafy Hafez
Hanafy Hafez
DYDina Yassin
Dina Yassin
MAMohamed Ashraf
Mohamed Ashraf
AEAlaa Elhaddad
Alaa Elhaddad
Acute myeloid leukemia (AML) is characterized by blocked or aberrant differentiation of hematopoietic stem cells. The MECOM gene overexpression in hematopoietic progenitors induces myeloid differen...

23 January 2020 in Pediatric Hematology and Oncology
Verified
Journal Article
Closed access
WZWael Zekri
Wael Zekri
MHMahmoud Hammad
Mahmoud Hammad
WRWafaa Rashed
Wafaa Rashed
GAGehad Ahmed
Gehad Ahmed
MEMaged Elshafie
Maged Elshafie
Ahmad Samir AlfaarAhmad Samir Alfaar
Ahmad Samir Alfaar
Adrenocortical carcinoma (ACC) is a rare, aggressive endocrine neoplasm. Complete surgical resection is the single most important treatment. Most available information has been learned from experience with its more frequent adult counterpart. In this study, we assessed the features and survival outcome of patients with ACC at Children’s Cancer Hospital Egypt (CCHE). Patients diagnosed at CCHE between July 2007 and November 2016 were followed up on until November 2018. Patients with stages I and II were operated upon, while stages III and IV had received combinations of doxorubicin, etoposide, platinol, and mitotane (DEPM) beside the attempt to conduct surgery when feasible. Data belonging to 18 patients (7 men and 11 women) were analyzed; median age at diagnosis was 48.5 months. Sixteen patients had presented with secreting tumors. Six patients were diagnosed with stage I disease; four with stage II; three with stage III; and five with stage IV carcinoma. By the end of this study, 10 patients have survived; five-year overall survival of 66.3%. Surviving patients were all of stage I or II diseases and were all in remission. Seven patients who did not survive died due to tumor progression, while one patient died after chemotherapy. The prognosis of ACC is essentially dependent on a successful complete resection of the tumor and thus on the initial tumor stage. The mitotane and DEP protocols may help control tumor growth in the advanced stages for only short periods.

15 August 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
YMYoussef Madney
Youssef Madney
LSLobna Shalaby
Lobna Shalaby
MHMahmoud Hammad
Mahmoud Hammad
MEMervat El-Anany
Mervat El-Anany
RHReem Mostafa Hassan
Reem Mostafa Hassan
RKReham Khedr
Reham Khedr
Patients with COVID-19 are at risk of developing secondary complications such as invasive pulmonary aspergillosis and mucormycosis. This is a retrospective study including all cancer children diagnosed with COVID-19-associated pulmonary fungal infection (CAPFI) during the period 2020–2021. A total of 200 patients were diagnosed with COVID-19, out of which 21 (10%) patients were diagnosed with CAPFI, 19 patients (90%) with COVID-aspergillosis (CAPA), and 2 (10%) patients with COVID-mucormycosis (CAM). Patients with CAPFI were classified using the “2020 ECMM/ISHAM consensus criteria”; proven in 2 (10%) patients, probable in 12 (57%), and possible in 7 (33%) patients. Although the hematological malignancy patients were already on antifungal prophylaxis, breakthrough fungal infection was reported in 16/21 (75%), 14 (65%) patients had CAPA while on echinocandin prophylaxis, while 2 (10%) patients had CAM while on voriconazole prophylaxis. Overall mortality was reported in 8 patients (38%) while CAPFI-attributable mortality was reported in 4 patients (20%). In conclusion, clinicians caring for pediatric cancer patients with COVID-19 should consider invasive pulmonary fungal infection, even if they are on antifungal prophylaxis, especially with worsening of the clinical chest condition. A better understanding of risk factors for adverse outcomes may improve clinical management in these patients.